Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Andreas Berting
Observed name:
A. Berting
Institution:
Baxter (Austria)
Observed institutions:
Max Planck Society,
Justus-Liebig-Universität Gießen,
Baxter (Austria),
Max Planck Institute of Biochemistry
OpenAlex ID:
A5024882548
Virus susceptibility of Chinese hamster ovary (CHO) cells and detection of viral contaminations by adventitious agent testing
2010
·
Andreas Berting
, Maria R. Farcet
, et al.
·
Biotechnology and Bioengineering
·
107
PDF
West Nile virus and the safety of plasma derivatives: verification of high safety margins, and the validity of predictions based on model virus data
2003
·
Thomas R. Kreil
, Andreas Berting
, et al.
·
Transfusion
·
81
A new liquid intravenous immunoglobulin with three dedicated virus reduction steps: virus and prion reduction capacity
2007
·
G. Poelsler
, A. Berting
, et al.
·
Vox Sanguinis
·
53
Computer-Aided Studies on the Spatial Structure of the Small Hepatitis B Surface Protein
1995
·
A. Berting
, J. Hahnen
, et al.
·
Intervirology
·
53
Removal of small nonenveloped viruses by antibody‐enhanced nanofiltration during the manufacture of plasma derivatives
2006
·
Thomas R. Kreil
, Andreas Wieser
, et al.
·
Transfusion
·
51
Neutralization of human parvovirus B19 by plasma and intravenous immunoglobulins
2007
·
Jens Modrof
, Andreas Berting
, et al.
·
Transfusion
·
50
Integrity of c-Raf-1/MEK signal transduction cascade is essential for hepatitis B virus gene expression
2003
·
Lars Stöckl
, Andreas Berting
, et al.
·
Oncogene
·
45
The integration of a major hepatitis B virus gene into cell-cycle synchronized carrot cell suspension cultures and its expression in regenerated carrot plants
2002
·
J. Imani
, A. Berting
, et al.
·
Plant Cell Tissue and Organ Culture (PCTOC)
·
42
Chikungunya virus and the safety of plasma products
2012
·
Sandra M. Leydold
, Maria R. Farcet
, et al.
·
Transfusion
·
33
Optimised Conditions for the Production of Hepatitis B Virus from Cell Culture
2001
·
Dieter Glebe
, Andreas Berting
, et al.
·
Intervirology
·
28
H5N1 influenza virus and the safety of plasma products
2007
·
T.R. Kreil
, U. Unger
, et al.
·
Transfusion
·
24
Inactivation of parvovirus B19 during STIM‐4 vapor heat treatment of three coagulation factor concentrates
2008
·
Andreas Berting
, Jens Modrof
, et al.
·
Transfusion
·
14
The evolution of down‐scale virus filtration equipment for virus clearance studies
2014
·
Andreas Wieser
, Andreas Berting
, et al.
·
Biotechnology and Bioengineering
·
13
Effective poxvirus removal by sterile filtration during manufacture of plasma derivatives
2005
·
A. Berting
, W. Goerner
, et al.
·
Journal of Medical Virology
·
10
Virus Filtration and Flow Variation: An Approach To Evaluate Any Potential Impact on Virus Retention
2016
·
A. Wieser
, A. Berting
, et al.
·
PDA Journal of Pharmaceutical Science and Technology
·
8
Parallel Evaluation of Broad Virus Detection Methods
2014
·
J. Modrof
, A. Berting
, et al.
·
PDA Journal of Pharmaceutical Science and Technology
·
3
Subject Index Vol. 44, 2001
2001
·
F.M. Burlandy
, M.A. Rebello
, et al.
·
Intervirology
Contents Vol. 44, 2001
2001
·
F.M. Burlandy
, M.A. Rebello
, et al.
·
Intervirology
PDF
Author Index Vol. 44, 2001
2001
·
F.M. Burlandy
, M.A. Rebello
, et al.
·
Intervirology
PDF
Author/Subject Indexes Vol. 38, No. 1–2, 1995
1995
·
Wolfram H. Gerlich
, W.H. Gerlich
, et al.
·
Intervirology
Show more works
View as search
Works count:
20
Citation count:
615
H-index:
13
I10-index:
14
Year
Topic
Type